FG-4592

Efficacy and Safety of FG-4592 for Treatment of Anemia in Participants With Lower Risk Myelodysplastic Syndrome (MDS)

FG-4592 for Treatment of Anemia in Subjects With Chronic Kidney Disease Not on Dialysis

FG-4592 for Treatment of Anemia in Subjects With Chronic Kidney Disease

A Study to Evaluate the Effects of Multiple Doses of FG-4592 on the Exposure, Safety and Tolerability and Effect of Warfarin in Healthy Subjects

A Study to Evaluate the Dose-proportionality and Effects of FG-4592 in Healthy Young and Elderly Male and Female Subjects

A Study to Investigate the Exposure and Safety and Tolerability of a Single Dose of FG-4592 in Subjects With Moderately Diminished Liver Function Compared to Those With Normal Liver Function

Study of FG-4592 in Subjects With Chronic Kidney Disease in China

Study of FG-4592 in Subjects With End-Stage Renal Disease Receiving Maintenance Hemodialysis in China

Study to Investigate the Interaction Between FG-4592 and Rosiglitazone in Healthy Adult Subjects